In vitro as well as ex vivo studies in neuroblastoma cell lines and synaptosomes, respectively, demonstrated an enhanced Aβ peptide and α7 nAChR interaction, resulting in increased Tau pathology (Stancu et al., 2014). The gene discussed is MAPT; the disease is neuroblastoma.